WuXi Biologics Chosen for S&P Global Sustainability Yearbook 2024

WuXi Biologics, known as WuXi Bio (2269.HK), a prominent global Contract Research, Development, and Manufacturing Organization (CRDMO), proudly announces its selection for the prestigious S&P Global Sustainability Yearbook 2024 (“Yearbook”) in recognition of its outstanding sustainability performance throughout 2023.

The Yearbook celebrates companies across diverse industries that have showcased exemplary corporate sustainability practices, evaluated through the rigorous S&P Corporate Sustainability Assessment (CSA). Out of over 9,400 evaluated entities in the 2023 CSA, only 759 top-performing companies earned a spot in the 2024 Yearbook. WuXi Biologics distinguished itself by attaining a Top 1% S&P Global CSA Score.

In 2023, WuXi Biologics achieved a remarkable 29% reduction in greenhouse gas emissions intensity from its 2020 baseline. Moreover, the company surpassed its water consumption intensity reduction target ahead of schedule, upgrading its objective from an initial 18% to an ambitious 30% reduction by 2025 compared to the 2019 baseline. Committed to fostering Diversity, Equity, and Inclusion (DEI), WuXi Biologics boasts 47% female representation in managerial roles and sees 53% of STEM positions held by female employees.

Dr. Chris Chen, CEO of WuXi Biologics and Chairman of the Environmental, Social, and Governance (ESG) Committee, expressed satisfaction with the Yearbook recognition, emphasizing the company’s recent inclusions in the Dow Jones Sustainability World Index and the Dow Jones Sustainability Emerging Markets Index. These accolades reflect WuXi Biologics’ steadfast dedication to augmenting its ESG capabilities and driving sustainable growth for the betterment of the global community.

Sustainability lies at the core of WuXi Biologics’ operations. Over the past year, the company has achieved significant ESG milestones. In June, it pledged support for the Science Based Targets initiative (SBTi), committing to achieving net-zero greenhouse gas emissions by 2050. In September, WuXi Biologics joined the United Nations Global Compact, reinforcing its sustainability commitment. In November, the company received an AAA rating from MSCI ESG Ratings and earned EcoVadis Sustainability Rating’s prestigious Platinum Medal, the highest distinction awarded to evaluated companies.

Source Link

Newsletter Updates

Enter your email address below and subscribe to our newsletter